+Gqnetical ly o b e s e (ob/ob) m i c e have decreased Na K ATPase actlvlty, an e n z y m e t h a t transports carni ti ne and other smal l m o l e c u l e s accross cel l membranes.
Na K ATPase actlvlty, an e n z y m e t h a t transports carni ti ne and other smal l m o l e c u l e s accross cel l membranes.
Free carnitine levels in plasma of ob/ob mice w a s 33.0 + 2.9 ( + 1 S.D.) compared t o 45.6 + 2.7 in their non-obese l ittermates (p < .05). P l a s m a a c lcarnltines w e r e s i m i l a r i n the t w o groups o f anrmals. Serum levels of carnltine were low because o b e s e a n i m a l s e x c r e t e m o r e c a r n l t l n e a n d Icarnitines 1 n t h e i r urlne than control animals.
carnltine uptake f r o m peritoneal fluid w a s studied I n ~l a s m a , brown and white adloose tissue and organs.
U p t a k e .in ob/ob animal s wa's increased 2 hours after l ntraperltoneal Injection, but depreezed a t 4 and 6 hours compared t o control animals. Ccarnitine uptake I n brown adipose tissue (BAT) o f o b e s e animal s w a s stri kin ly depressed compared t o non-obese animal s, but upfake w a s simil ar in w h i t e ad1 pose tissue l lver and ki dne s. Decreased plasma carniti ne and' a l m o s t no carnyti ne uptake i n B A T e x p l a i n the a c c u m u l a t i o n of neutral lipids I n ob/ob mice, since less carnltine Is available to metabol ize long chain fatty aci ds. Altered carnitine metabol ism appears t o play a r o l e I n t h e obesity and decreased thermal response to stress observed in ob/ob mice. Children with renal Fanconi syndrome (FS) fail to reabsorb water, amino acids, glucose, electrolytes, and other small molecules including carnitine. In 21 FS patients (18 with cystinosis, the most common identifiable cause of FS in children), the mean urinary fractional excretions of free and acyl carnitines were 32% and 27%, resp., compared with control values of 3% and 5X, resp. (N=6).
Plasma free carnitine was 11.6t4.0 (SD) nmollml in FS and 42.0'9.0 in controls (p<0.001).
The plasma carnitine deficiency in FS was independent of age, cysteamine therapy, and renal glomerular function. The liver did not appear functionally carnitine-deficient in FS, since 2 patients exhibited a normal, 5 to 10-fold increase in 8-hydroxybutyrate and acetoacetate after a 24-hour fast. In 2 other patients with cystinosis and plasma carnitine deficiency, muscle free carnitines were 8.5 and 13.1 nmolfmg noncollagen protein (4 controls 19.2'2.5); total muscle carnitines were 11.8 and 13.3 (controls 24.8t7.5).
The greatest relative decrease in muscle carnitine was in the short chain acyl carnitine fraction. One muscle biopsy in a cystinosis patient revealed an increase in lipid droplets. A muscle biopsy in another patient showed a large increase in lipid droplets, small vacuoles, occasional "ragged-red" fibers, a slight increase in connective tissue, and variation in muscle fiber size. These myopathic changes, consistent with carnitine deficiency, may be amenable to therapy with L-carnitine replacement. Glucagon is a critical hormone for glucose homeostasis in the neonate since it stimulates glycogenolysis and induces gluconeogenic enzymes following birth. To determine its role in the development of hypoglycemia in the growth retarded neonate, we characterized glucoregulation in rat pups growth retarded by maternal bilateral uterine artery ligation (L) and in pups of sham (S) and nonoperated (N) mothers. Birthweight differed significantly (L 4.112.05; S 4.7e.04; N 5.68+.03 g; p<.01). L pups had significantly lower glucose concentrations at birth, 20 and 240 min. but had normal values at 60 and 120 min. Hepatic glycogen was significantly diminished in L pups. Glucagon in L pups increased significantly at 20 and 60 min (60 min: L 641+106; S 217231; N 318528 pgfml; p ( .01) while insulin decreased equivalently in all groups. PEPCK activity increased in S and N but not L pups (240 min: L .166+.03; S .392+.03: N .400+_.022 U moles PEP/g liverfmin; p < .0i). Pharmacologic doses of glucagon at birth (plasma conc: 76 to 143 x 103 pgfml) accelerated PEPCK induction and prevented hypoglycemia. By 120 min, L had PEPCK equivalent to S and N pups. Glucagon did not result in supranormal PEPCK in S and N. L pups developed biphasic hypoglycemia because of limited glycogen and delayed PEPCK induction. This delay results from an inadequate though increased glucagon release at birth or relative insensitivity to available endogenous glucagon.
RESPONSE OF VITAMIN D METABOLITES m CHRONIC SUBERY

TRANSEPIDERMAL EVAPORATIVE WATER LOSS OF PREMATURE INFANTS: EFFECTS OF SKIN COVER WITH PARAFFIN OR A
' TRANSPARENT ADHESIVE POLYURETHANE FILM. sergio A.
Bustamante and Ann Fiello, University of Arizona Health Sciences Center, Department of Pediatrics, Tucson, AZ Transepidermal evaporative water loss (TEWL) of premature infants is a significant problem affecting temperature regulation and fluid balance. High relative humidity and covers of various types have been used to reduce TEWL. Using a recently developed evaporimeter we measured TEWL in pr2mature infants simltaneously treated with high humidity, a paraffin ointment (PAR) or a transparent adhesive polyurethane film (TAP). The ten subjects were included in the study after parental consent, had a mean birth weight of 1652.50 gm (f 89.73; SEM) and gestation of 33.6 weeks (f 0.5; SEM), were cared for in incubators with servo-control of the temperature and entered the study at a mean age of 3.2 days (f 0.9; SEM). The relative humidity of the environment at the site of TEWL measures was 65.77% (+ 4.17; SEM). Each infant had one leg covered with PAR (70% solid and 30% liquid paraffin); the other leg was covered with TAP and the buttock area served as the control surface. TEWL measures were made once a day for four consecutive days with minimal disturbance of the subject. Each set of measures was combined to a mean TEWL per site per subject and then analyzed for statistical differences. The mean TEWL of the control was 3.78 gm of water per M~ per hour (f 0.30; SEM) , for the TAP group was 1.90 (f 0.26) and for the PAR group 3.03 (f 0.28). TAP is significantly better than PAR (P <0.01) and high relative humidity alone (P <0.01) to reduce TEWL. Clinical and biochemical features included severe rickets, muscle weakness, inability to stand, growth retardation, hypocalcemia, elevated serum PTH, normal 25(OH)D, low plasma osteocalcin and extremely high serum levels of 1,25-(OH12D. One dead brother in kindred B had rickets. Both children were treated with 1,15(OH)2D3 at 10 mcg P.O. twice daily (5rncglml R0-21-5535 Hoffman-LaRoche Lab.) and had good improvement with megadoses of 1,25(DH)2D without toxicity. There were features suggesting more severe disease in kindred A versus B.
MANIFESTATIONS
Partial alopecia was present only in the proband of A. Serum levels of 1,25(OH)2D associated with normalization of serum Ca were higher in A (>4.000 pg/ml vs 468 pglml).
Soluble extracts from cultured dermal fibroblasts revealed that interactions with 1,25(OH)2D were more abnormal in kindred A than B. The Kd for hormone binding was 2.7 vs 2.0 nM (nl 0.13i0.02) and capacity for binding was 19 vs 30 femtomoles/mg protein (nl 32t2). The 24cOH)D 24-hydroxylase response to a high concentration of 1,25-(OH)2D3 was undectable in A vs 0.5 picomoles x 106 cells/30m.
in El (nl 8.2t1.5).
These are the only two known kindreds with a hereditary resistance to 1,25(OH)2D associated with low hormone affinity of the receptors. Our results revealed a close relationship between severity of the disease in vivo and indices of 1,25(OH)2D3 interaction with cells in v i t r r
